Boulder, CO – According to filings with the U.S. Securities and Exchange Commission, Arpeggio Biosciences is raising $20,279,156.00 in new funding. Sources indicate as part of senior management President, Joseph Azofeifa played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Arpeggio Biosciences
Our technology combines a proprietary biological assay and machine learning algorithms that, together, enable rapid, high-resolution snapshots of cellular dynamics following drug treatment. These snapshots are then analyzed to reveal the biological networks that determine a drugs function and guide therapeutic development. We are comprised of a talented, diversely-skilled team, working together towards the mission of helping bring new therapies to patients with epigenetically-driven diseases.

To learn more about Arpeggio Biosciences, visit http://arpeggiobiosciences.com/

Contact:
Joseph Azofeifa, President
720-234-6142
jazofeifa@arpeggiobiosciences.com
https://www.linkedin.com/in/joey-azofeifa-060070130/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved